Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Dr. Derrick Phillips

Dr. Derrick Phillips, BSc, MS, Ph.D.

Postdoctoral Fellow

Dr. Phillips served as the first postdoctoral fellow in the Zanos lab.

His research focused on understanding the effects of different drugs of abuse on sleep architecture during chronic administration, as well as following protracted abstinence.

Following his postdoctoral training in the Zanos lab, he secured a faculty position at the University of Idaho, USA, as an Assistant Professor of Circadian Biology.

Selected Publications

 
  • Phillips DJ., Powels C., Zanos P. Protracted abstinence from chronic opioid administration induces REM-specific sleep disturbances in mice. In Preparation.
  • Smith PC, Phillips DJ, Pocivavsek A, Byrd CA, Viechweg SS, Hampton B et al. Estradiol influences adenosinergic signaling and nonrapid eye movement sleep need in adult female rats. Sleep 2022; 45(3). https://doi.org/10.1093/sleep/zsab225.

Recent Posts

  • New Publication in Neuroscience & Biobehavioral Reviews: A Hierarchical Framework for Nociplastic Pain September 11, 2026
  • Dr. Charalambous presents brain aging research at AAIC 2026 July 13, 2026
  • Mapping the Epstein-Barr Virus-Multiple Sclerosis Axis: Dr. Anna Onisiforou presents VirTrack and VirTarget at the FENS Forum 2026 July 9, 2026
  • Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026 July 8, 2026
  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress